Fed. Circ. Agrees To Speed Up Args In COVID Vax Patent Case
The Federal Circuit on Monday agreed to accelerate the schedule in a COVID-19 vaccine patent dispute between Moderna and Arbutus Biopharma Corp. by holding arguments in November....To view the full article, register now.
Already a subscriber? Click here to view full article